does masshealth cover glp-1 More states consider dropping weight loss drugs from Medicaid • Stateline The Massachusetts Group Insurance Commission

Many patients report that they simply forget to eat or feel full after just a few bites

Some research suggests that GLP-1s containing tirzepatide (Zepbound, Mounjaro) may help lower the risk of further complications in people with cardiovascular disease

At present: There is no strong evidence that GLP-1 receptor agonists directly cause universal micronutrient deficiency

Ertugliflozin Ertugliflozin (Steglatro) is the most recent SGLT-2 inhibitor to come to the market, with approval for use in people with T2D received from the EMA in 2018 and the FDA in 2017

Its always best to speak with your doctor when adding new supplements to your regimen, particularly in an effort to avoid medication interactions." 2